Anti-CCR5/CD195 Antibody (Leronlimab)
Catalog No.
F1114
Anti-CCR5/CD195 Antibody (Leronlimab)
Featured Products
Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody. Leronlimumab inhibits CCR-mediated HIV-1 virus and lung metastasis in mouse tumor models. Leronlimab can be used in the study of HIV nonalcoholic steatohepatitis (NASH) and cancer.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
150 kDa
Dry ice
674782-26-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
HUPRO-140, PRO-140
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P51681
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
Human CCR5 His EGFP HEK293 cells were stained with Anti-CCR5/CD195 Antibody (Leronlimab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS
CCR5 / CD195
Please avoid freeze-thaw cycles.